David Holden

ITL Health Group Ltd. engages in the development, manufacture, distribution, and sale of innovative medical devices and medical procedure packs. It operates through the following segments: ITL BioMedical, Healthcare Australia, and MyHealthTest. The ITL BioMedical segment designs, manufactures, markets, and distributes tools for blood management and clinical procedures. The Healthcare Australia segment provides medical and surgical solutions to suit the individual needs of both public and private hospitals throughout Australia. The MyHealthTest segment is a Canberra based medical biotech company which provides direct consumer pathology testing. The company was founded by William Leonard Mobbs in 1994 and is headquartered in Kingston, Australia.